MGMT and glioblastoma: Moreover, we recently reported [24] that the HPLC method was a powerful tool in glioblastoma cases to evaluate the methylation status of the MGMT gene, which is a well-known biomarker to predict the clinical response to temozolomide in glioblastoma cases [25,26].